Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Rheum Dis Clin North Am[TA])
1,569 results
  • Malignancy and Janus Kinase Inhibition. [Review]
  • RDRheum Dis Clin North Am 2017; 43(1):79-93
  • Sivaraman P, Cohen SB
  • The use of biologics such as anti-tumor necrosis factor and oral Janus kinase inhibitors have revolutionized the treatment of rheumatoid arthritis (RA). The risk of malignancies such as lymphomas, lu...
  • Malignancy and the Risks of Biologic Therapies: Current Status. [Review]
  • RDRheum Dis Clin North Am 2017; 43(1):43-64
  • Seror R, Mariette X
  • Cancer is a common event in patients with rheumatic diseases. In some cases, the disease, its risk factors, or its treatment could play a role in favoring cancer. This article analyzes the current kn...
New Search Next